Literature DB >> 16339585

Expression and activity of NOX5 in the circulating malignant B cells of hairy cell leukemia.

Aura S Kamiguti1, Lena Serrander, Ke Lin, Robert J Harris, John C Cawley, David J Allsup, Joseph R Slupsky, Karl-Heinz Krause, Mirko Zuzel.   

Abstract

Hairy cells (HCs) are mature malignant B cells that contain a number of constitutively active signaling molecules including GTP-bound Rac1, protein kinase C, and Src family kinases. Because Rac1 is a component of the reactive oxidant species (ROS)-generating NADPH oxidase system, we investigated the role of this GTPase in ROS production in HCs. In this study, we show that ROS production in HCs involves a flavin-containing oxidase dependent on Ca2+, but not on GTP-Rac1 or protein kinase C. This suggests the involvement of the nonphagocytic NADPH oxidase NOX5, an enzyme found in lymphoid tissues, but not in circulating lymphocytes. By using RT-PCR and Southern and Western blotting and by measuring superoxide anion production in membrane fractions in the absence of cytosolic components, we demonstrate for the first time that HCs (but not circulating normal B cells or some other lymphoid cell types) express NOX5. We also demonstrate that inhibition of NADPH oxidase in HCs results in a selective increase in the activity of Src homology region 2 domain-containing phosphatase 1 (SHP-1). Furthermore, SHP-1 in HCs coimmunoprecipitates with tyrosine phosphorylated CD22 and localizes in the same cellular compartment as NOX5. This allows the inactivation of SHP-1 by NOX5-generated ROS and contributes to the maintenance of the constitutive activation of HCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16339585     DOI: 10.4049/jimmunol.175.12.8424

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Central role of protein kinase Cepsilon in constitutive activation of ERK1/2 and Rac1 in the malignant cells of hairy cell leukemia.

Authors:  Joseph R Slupsky; Aura S Kamiguti; Robert J Harris; John C Cawley; Mirko Zuzel
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

2.  PRAME expression in hairy cell leukemia.

Authors:  Evgeny Arons; Tara Suntum; Inger Margulies; Constance Yuan; Maryalice Stetler-Stevenson; Robert J Kreitman
Journal:  Leuk Res       Date:  2008-03-04       Impact factor: 3.156

Review 3.  Nox5 and the regulation of cellular function.

Authors:  David J R Fulton
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

Review 4.  Nox enzymes in immune cells.

Authors:  William M Nauseef
Journal:  Semin Immunopathol       Date:  2008-05-01       Impact factor: 9.623

5.  Nox5 forms a functional oligomer mediated by self-association of its dehydrogenase domain.

Authors:  Tsukasa Kawahara; Heather M Jackson; Susan M E Smith; Paul D Simpson; J David Lambeth
Journal:  Biochemistry       Date:  2011-03-04       Impact factor: 3.162

Review 6.  Enzymatic regulation and functional relevance of NOX5.

Authors:  Feng Chen; Yusi Wang; Scott Barman; David J R Fulton
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

7.  GTPase-Rac enhances depolarization-induced superoxide production by the macula densa during tubuloglomerular feedback.

Authors:  Ruisheng Liu; Luis A Juncos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-09       Impact factor: 3.619

8.  Identification of a conserved Rac-binding site on NADPH oxidases supports a direct GTPase regulatory mechanism.

Authors:  Yu-Ya Kao; Davide Gianni; Benjamin Bohl; Ross M Taylor; Gary M Bokoch
Journal:  J Biol Chem       Date:  2008-03-17       Impact factor: 5.157

9.  NADPH oxidase-generated reactive oxygen species are required for stromal cell-derived factor-1α-stimulated angiogenesis.

Authors:  Xinchun Pi; Liang Xie; Andrea L Portbury; Sarayu Kumar; Pamela Lockyer; Xi Li; Cam Patterson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07-02       Impact factor: 8.311

Review 10.  Nox proteins in signal transduction.

Authors:  David I Brown; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2009-07-21       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.